Heard on the Street: Investors have bet new cancer drugs can topple Merck’s Keytruda, but the evidence so far points to something smaller

Investors have bet new drugs can topple Merck’s Keytruda, but the evidence so far points to something smaller.

Investors have bet new drugs can topple Merck’s Keytruda, but the evidence so far points to something smaller.

Investors have bet new drugs can topple Merck’s Keytruda, but the evidence so far points to something smaller.